HNB
VKTX icon

Huntington National Bank’s Viking Therapeutics VKTX Stock Holding History

Huntington National Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
2,815
+38
+1% +$1.23K ﹤0.01% 1117
2026
Q1 		$90.4K Buy
2,777
+75
+3% +$2.41K ﹤0.01% 1113
2025
Q4 		$95.1K Sell
2,702
-485
-15% -$17.2K ﹤0.01% 997
2025
Q3 		$83.8K Buy
3,187
+491
+18% +$14.6K ﹤0.01% 1049
2025
Q2 		$71.4K Buy
2,696
+196
+8% +$5.16K ﹤0.01% 1112
2025
Q1 		$60.4K Hold
2,500
– – ﹤0.01% 1111
2024
Q4 		$101K Buy
+2,500
New +$143K ﹤0.01% 934

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Huntington National Bank's VKTX Position: Q2 2026 in Review

Huntington National Bank increased its Viking Therapeutics (VKTX) stake by 1.4% in Q2 2026, buying an estimated $1.23K and bringing the position to 2,815 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Huntington National Bank first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Huntington National Bank held 2,815 shares of Viking Therapeutics worth $110K as of Q2 2026.
  • Huntington National Bank bought 38 Viking Therapeutics shares in Q2 2026, an estimated $1.23K.
  • Viking Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1117 holding.
  • Huntington National Bank first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.